Akèy › Kansè vejik › Pennsylvania › Lancaster
Etid klinik pou Kansè vejik nan Lancaster, PA
3 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Lancaster (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Ap rekriteFaz 3
- Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Ap rekriteFaz 2
- Keystone Urology Specialists, Lancaster
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Ap rekriteFaz 1
- Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster
Etid Kansè vejik nan lòt vil
- New York City, NY35 etid
- Nashville, TN31 etid
- Houston, TX31 etid
- Dallas, TX27 etid
- Boston, MA26 etid
- Washington, DC26 etid
- Los Angeles, CA24 etid
- Baltimore, MD24 etid
- St. Louis, MO22 etid
- Philadelphia, PA21 etid
- Seattle, WA21 etid
- Edison, NJ21 etid
Lòt etid nan Lancaster
- Kansè Poumon ki pa ti selil7 etid
- Ensifizyans kadyak5 etid
- Maladi kadyovaskilè5 etid
- Kansè pwostat4 etid
- Kansè Metastatik4 etid
- Kansè nan tete4 etid
- Kansè poumon3 etid
- Amblyopi3 etid
- Maladi kè3 etid
- Kansè Vezik ki pa envazif miskilè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.